Skip to main content
SpringerLink
Log in

Hormon- und Chemotherapie

  • Chapter
Mammatumoren / Tumours of the Mammary

Part of the book series: Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology ((1528,volume 19 / 2))

  • 21 Accesses

Zusammenfassung

Das Mammakarzinom ist ein Malignom, das fast ausschließlich durch Fernmetastasierung und nicht durch lokales Tumorwachstum zum Tode führt. Rund 60% aller Patientinnen mit Mammakarzinom entwickeln innerhalb von zehn Jahren nach der primären Therapie Metastasen (Seidman, 1969). Langfristig können nur etwa 25% aller Patientinnen mit Mammakarzinom definitiv geheilt werden (Welbourn U. Burn, 1972). Das Risiko, nach erfolgreicher Radikaloperation eines Mammakarzinoms infolge Fernmetastasierung zu sterben, besteht auch noch nach einer Beobachtungsdauer von mehr als 20 Jahren (Ederer etal, 1963; Whitney et al, 1964). Rund 75% aller Patientinnen mit diesem Karzinom benötigen daher zu irgendeinem Zeitpunkt eine palliative Behandlung in einem nicht heilbaren Stadium. Der klinische Verlauf des Mammakarzinoms ist sehr unterschiedlich. Einige Karzinome führen rasch zum Tode, unabhängig davon, welche kurativen oder palliativen Therapien eingeleitet werden. Andere zeigen sehr langsame Verläufe. Dazwischen liegen zahlreiche Krankheitsverläufe, die heute in zunehmendem Maße auch im metastasierenden Stadium objektiv und subjektiv günstig beeinflußt werden können. Die großen Unterschiede im Spontanverlauf des Mammakarzinoms machen es schwierig, ohne exakt definierte Kriterien die Wirksamkeit irgendeiner Behandlungsmethode zu bewerten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahman, D.L., Eagan, R.T., Bisel, H.F., Hahn, R.G., O’Connell, M.J., Edmondson, J.H.: Evaluation of combination therapy with adriamycin (NSC-123 127) and methotrexate (NSC-740) in patients with disseminated breast cancer. Cancer Chemother. Rep. 6/3, 335–338 (1975a)

    Google Scholar 

  • Ahman, D.L., Bisel, H.F., Hahn, R.G. et al.: An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-Fluorouracil, cyclophosphamide, and prednisone with or without vincristine. Cancer 36, 1925–1935 (1975b)

    Article  Google Scholar 

  • Ahman, D.L., O’Connell, M.J., Hahn, R.G. Bisel, H.F., Lee, R.A., Edmondson, J.H.: An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. N. Engl. J. Med. 29, 356–360 (1977)

    Article  Google Scholar 

  • Band, P.R., Tormey, D.C., Bauer, M.: Induction chemotherapy and maintenance chemo-hormontherapy in metastatic breast cancer (abstr.). Proc. Am. Assoc. Cancer Res. 18, 228 (1977)

    Google Scholar 

  • Baulieu, E.E.: Steroid receptors and hormone receptivity: new approaches in pharmacology and therapeutics. In: Breast cancer, trends in research and treatment. Heuson, J.C., Mattheiem, W.H., Rozencweig, M. (eds.), pp. 165–183. New York: Raven Press 1977

    Google Scholar 

  • Benjamin, R.S., Wiernik, P.H., Bachur, N.R.: Adriamycinefficacy, safety, and pharmacologic basis of a single dose schedule (abstr.). Cancer Chemother. Rep. 57, 98 (1973)

    Google Scholar 

  • Blumenschein, G., Cardenas, J., Freireich, E., Gottlieb, J.: FAC chemotherapy for breast cancer (abstr.). Proc. Am. Assoc. Cancer Res. 15, 193 (1974)

    Google Scholar 

  • Bogden, A.E., Ebber, H.J., Taylor, D.J., Gray, J.H.: Comparative study of surgery, chemotherapy and immunotherapy alone and in combination on metastases of 13762 mammary adenocarcinoma. Cancer Res. 34, 1627–1631 (1974)

    PubMed  CAS  Google Scholar 

  • Bonadonna, G., Monfardini, S., DeLena, M., Fossati-Bellani, F., Beretta, G.: Clinical trials with adriamycin. Results of a three-year study. In: International symposium on adriamycin. Carter, S.K., Di-Marco, A., Ghione, M., Krakoff, I.H., Mathé, G. (eds.), pp. 139–152. Berlin, Heidelberg, New York: Springer 1972

    Chapter  Google Scholar 

  • Bonadonna G., Rossi, A., Valagussa, P., Banfi, A., Veronesi, U.: The C.M.F program for operable breast cancer with positive axillary nodes. Cancer 39, 2904–2915 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Broder, L.E., Tormey, D.C.: Combination chemotherapy of carcinom of the breast. Cancer Treat. Rev. 1, 183–203 (1974)

    Article  Google Scholar 

  • Brunner, K.W., Nagel, G.A.: Internistische Krebstherapie. Berlin, Heidelberg, New York: Springer 1976

    Google Scholar 

  • Brunner, K.W., Sonntag, R.W., Martz, G., Senn, H.J., Obrecht, P., Alberto, P.: A controlled study in the use of combined drug therapy for metastatic breast cancer. Cancer 36, 1208–1219 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Brunner, K.W., Sonntag, R.W., Alberto, P., Senn, H.J., Martz, G., Obrecht, P.: Combined chemo-and hormonal therapy in advanced breast cancer. Cancer 39, 2923–2933 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Canellos, G.P., Taylor, S.G., Band, P., Pocock, S.: Combination chemotherapy for advanced breast cancer (abstr.). Proc. XIth Int. Cancer Congr. 3, 596 (1974)

    Google Scholar 

  • Canellos, P.G., Pocock S.J., Taylor, S.G. et al.: Combination chemotherapy for metastatic breast carcinoma. Cancer 38, 1882–1886 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Carbone, P.P., Bauer, M., Band, P., Tormey, D.: Chemotherapy of disseminated breast cancer. Cancer 39, 2916–2922 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Carter, S.K.: Chemotherapy of breast cancer: current status. In: Breast cancer, trends in research and treatment. Heuson, J.C., Mattheiem, W.H., Rozencweig, M. (eds.), pp. 196–215. New York: Raven Press 1976

    Google Scholar 

  • Cole, M.P.: Suppression of ovarian function in primary breast cancer. In: Prognostic factors in breast cancer. Forrest, A.P.M., Kunkler P.B. (eds.), p. 146. Edinburgh, London: Livingstone 1968

    Google Scholar 

  • Cooper, R.: Combination chemotherapy in hormone resistant breast cancer (abstr.). Proc. Am. Assoc. Cancer Res. 10, 15 (1969)

    Google Scholar 

  • Cortes, E.P., Holland, J.F., Wang, J.J., Sinks, L.F., Blom, J., Senn, H.J., Bank, A., Glidewell, O.: Amputation and adriamycin in primary osteosarcoma. N. Engl. J. Med. 291, 998–1002 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Creech, R., Harris, D., Grotzinger, P., Engstrom, P.: Low dose therapy of metastatic breast cancer with CAMF vs. sequential C.M.F and adriamycin (abstr.). Proc. Am. Soc. Clin. Oncology 18, 300 (1977)

    Google Scholar 

  • Davis, H.L., Ramirez, G., Ellerby, R.A., Ansfield, F.J.: Five-drug therapy in advanced breast cancer. Factors influencing toxicity and response. Cancer 34, 239–245 (1974)

    Article  PubMed  Google Scholar 

  • DeJager, R., Kaufman, R., Ocahoa, M., Krakoff, L.H.: Chemotherapy of advanced breast cancer with a combination of Cytoxan, adriamycin, and 5-FU (CAF) (abstr.). Proc. Am. Assoc. Cancer Res. 16, 273 (1975)

    Google Scholar 

  • DeLena, M., DePalo, G.M., Bonadonna, G., Beretta, G., Bajetta, E.: Terapia del carcinoma mammario metastatizzato con ciclofosfamide, methotrexate, vincristina e fluorouracile. Tumori 59, 11–24 (1973)

    CAS  Google Scholar 

  • DeLena, M., Brambilla, C., Morabito, A., Bonadonna, G.: Adriamycin plus vincristine compared with cyclophosphamide, methotrexate and 5-fluorouracil for advanced breast cancer. Cancer 35, 1108–1115 (1975)

    Article  CAS  Google Scholar 

  • Eagan, R.T., Ahman, D.L., Admondson, J.H., Hahn, G., Bisel, H.F.: Controlled evaluation of the combination of adriamycin (NSC-123 127), vincristine (NSC-67 574) and methotrexate (NSC-740) in patients with disseminated breast cancer. Cancer Chemother. Rep. 6/3, 339–342 (1975)

    Google Scholar 

  • Ederer, R., Cutler, S.J., Goldenberg, I.S., Eisenberg, H.: Causes of death among long-term survivors from breast cancer in Connecticut. J. Natl. Cancer Inst. 30, 933–947 (1963)

    Google Scholar 

  • Fernbach, D.J., Martyn, D.T.: Role of dactinomycyn in the improved survival of children with Wilms’ tumor. J. Am. Med. Assoc. 195, 1005–1009 (1966)

    Article  CAS  Google Scholar 

  • Fisher, B., Ravdin, R.G., Ausman, R.K., Slack, N.H. et al.: Surgical adjuvant chemotherapy in cancer of the breast. Results in a decade of cooperative investigation. Ann. Surg. 168, 337–356 (1968)

    Article  PubMed  CAS  Google Scholar 

  • Fisher, B., Slack, N, Bross, I.D.J., et al.: Cancer of the breast: size of neoplasm and prognosis. Cancer 24, 1071–1080 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Fisher, B., Slack, N., Katrych, D., Wolmark, N.: Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg. Gynecol. Obstet. 140, 528–534 (1975)

    PubMed  CAS  Google Scholar 

  • Fisher, B. et al.: L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. Cancer 39, 2883–2901 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Forrest, A.P.M., Kunkler, P.B. (eds.): Prognostic factors in breast cancer. Edinburgh, London: Livingstone 1968

    Google Scholar 

  • Fracchia, A.A., Farrow, J.H., Miller, T.R., Rollefsen, R.H., Greenberg, E.J., Knapper, W.H.: Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast. Surg. Gynecol. Obstet. 133, 241–246 (1971)

    PubMed  CAS  Google Scholar 

  • Greenspan, E.: Response of advanced breast cancer to the combination of the antimetabolite, methotrexate, and the alkylating agent thio-tepa. Mt. Sinai J. Med. N.Y. 30, 246–267 (1963)

    CAS  Google Scholar 

  • Greenspan, E.: Combination cytotoxic chemotherapy in advanced disseminated breast cancer. Mt. Sinai J. Med. N.Y. 33, 1–27 (1966)

    CAS  Google Scholar 

  • Grinberg, R., Nemoto, T., Dao, T.L.: Vincristine: dosage and response in breast cancer. Cancer Chemother. Rep. 45, 57–61 (1965)

    PubMed  CAS  Google Scholar 

  • Groupe Européen du Cancer du Sein: Le traitement hormonal du cancer du sein en phase avancée: Comparaison entre le propionate de testosterone et la combinaison propionate de testosterone — delta-1 testololactone. Rev. Fr. Etud. Clin. Biol. 9, 88–90 (1964)

    Google Scholar 

  • Hanham, I.W.F., Newton, K.A., Westbury, G.: Seventy-five cases of solid tumors treated by a modified quadruple chemotherapy regime. Br. J. Cancer 25, 462–478 (1971)

    Article  PubMed  CAS  Google Scholar 

  • Harvey, H.A., White, D.S., Lipton, A.: Five drug regimen plus adriamycin in metastatic breast cancer (abstr.). Proc. Am. Soc. Clin. Oncology 16, 255 (1975)

    Google Scholar 

  • Holland, J., Sharlav, C., Galiani, S. et al.: Vincristine treatment of advanced cancer: a comparative study of 392 cases. Cancer Res. 33, 1258–1264 (1973)

    PubMed  CAS  Google Scholar 

  • Hoogstraten, B.: Adriamycin (NSC-123 127) in the treatment of advanced breast cancer: studies by the Southwest Oncology Group. Cancer Chemother. Rep. 6/3, 329–334 (1975)

    Google Scholar 

  • Hoogstraten, B., George, S.L., Samal, B. etal.: Combination chemotherapy and adriamycin in patients with advanced breast cancer. Cancer 38, 13–20 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Horton, J., Dao, T., Cunningham, T., Nemoto, T. et al.: Alternating combination therapy for metastatic breast cancer (abstr.). Proc. Am. Soc. Clin. Oncology. 17, 247 (1976)

    Google Scholar 

  • Jaffe, N. et al.: Adjuvant methotrexate and citrovorumfactor for treatment of osteogenic sarcoma. N. Engl. J. Med. 291, 944–948 (1974)

    Article  Google Scholar 

  • James, D.H.: Combination chemotherapy of childhood neuroblastoma. J. Am. Med. Assoc. 194, 123–128 (1965)

    Article  Google Scholar 

  • Kennedy, B.J., Mielke, P.W. Jr, Fortuny, I.E.: Therapeutic castration versus prophylactic castration in breast cancer. Surg. Gynecol. Obstet. 118, 524–529 (1964)

    PubMed  CAS  Google Scholar 

  • Leclercq, G., Heuson, J.C., Deboel, M.C., Mattheiem, W.H.: Oestrogen receptors in breast cancer. A changing concept. Br. Med. J. 1975 1, 185–189

    Article  PubMed  CAS  Google Scholar 

  • Leone, L.S., Rege, V.: Treatment of metastatic, recurrent or inoperable carcinoma of breast with VCR/ Pred/5-FU/Mtx/Cyclo (Reg I) vs. VCR/Pred/5-FU (Reg II) (abstr.). Proc. Am. Assoc. Cancer Res. 14, 125 (1973)

    Google Scholar 

  • Lloyd, R., Jones, S.E., Salmon, S.E., and Southwest Oncology Group Members: Phase II trial of adriamycin and cyclohphosphamide: a Southwest Oncology Group Pilot Study. Proc. Am. Assoc. Cancer Res. 16, 265 (1975)

    Google Scholar 

  • Lokich, J.J., Skarin, A.T.: Five drug combination chemotherapy for disseminated adenocarcinoma. Cancer Chemother. Rep. 56, 761–787 (1972)

    PubMed  CAS  Google Scholar 

  • McGuire, W.L., Carbone, P.P., Vollmer, E.P. (eds.): Estrogen receptors in human breast cancer. New York: Raven Press 1975

    Google Scholar 

  • McGuire, W.L., Horwitz, K.B, Pearson, O.H., Segaloff, A.: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39, 2934–2974 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Middleman, E., Luce, J.K., Frei, E.: Clinical trials with adriamycin. Cancer 28, 844–50 (1971)

    Article  PubMed  CAS  Google Scholar 

  • Muss, H.B., White, D.R., Cooper, M.R., Richards, F.C., Spurr, C.L.: A randomyzed study of two five-drug regimens in advanced breast cancer (abstr.). Proc. Am. Soc. Clin. Oncology 18, 272 (1977)

    Google Scholar 

  • Nemoto, T., Horton, J., Cunningham, T. etal.: Up date report: comparison of combination chemotherapy (FCP) vs. adriamycin (ADM) vs. adrenalectomy (ADX) in breast cancer (abstr.). Proc. Am. Assoc. Cancer Res. 16, 46 (1975)

    Google Scholar 

  • Philips, R.F., Higinbotham, N.Z.: The curability of Ewing’s endothelioma of bone in children. J. Pediatr. 70, 391–398 (1967)

    Article  Google Scholar 

  • Rozencweig, M., Heuson, J.-A.: Breast cancer: prognostic factors and clinical evaluation. In: Cancer therapy: prognostic factors and criteria of response. Staquet, M.J. (ed.), pp. 139–183. New York: Raven Press 1975

    Google Scholar 

  • Salmon, S., Jones, S.: Chemotherapy of advanced breast cancer with a combination of adriamycin and cyclophosphamide (abstr.). Proc. Am. Assoc. Cancer Res. 15, 90 (1974)

    Google Scholar 

  • Schabel, F.M.: Concepts for systemic treatment of micrometastases. Cancer 35, 15–24 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Schabel, M.F.: Rationale for adjuvant chemotherapy. Cancer [Suppl.] 39, 2846–2867 (1977)

    Google Scholar 

  • Seidman, H.: Cancer of the breast: statistical and epidemiological data. Cancer 24, 1355–1378 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Smalley, R., Bornstein, R.: C-A-F treatment of metastatic breast carcinoma (abstr.). Proc. Am. Assoc. Cancer Res. 16, 265 (1975)

    Google Scholar 

  • Smalley, R.V., Murphy, S., Chan, Y.K., Huguely, C.M.: Comparison of two five-drug regimens vs. sequential chemotherapy in metastatic breast carcinoma (abstr.). Cancer Chemother. Rep. 57, 110 (1973)

    Google Scholar 

  • Stolfi, R.L., Martin, D.S., Fugmann, R.A.: Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy. Cancer Chemother. Rep. 55, 239–249 (1971)

    PubMed  CAS  Google Scholar 

  • Stoll, B.A. (ed.): Mammary cancer and neuroendocrine therapy. London: Butterworths 1974

    Google Scholar 

  • Stutz, F.H., Blom, J., Tormey, D.C.: Combination chemotherapy in disseminated carcinoma of the breast. Oncology 29, 139–146 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Sutow, W.W.: Chemotherapy in childhood cancer (except leukemia). An appraisal. Cancer 18, 1585–1595 (1965)

    CAS  Google Scholar 

  • Sutow, W., Sullivan, P., Fernbach, D.: Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Proc. Am. Assoc. Cancer Res. 15, 20 (1974)

    Google Scholar 

  • Tormey, D.C.: Adriamycin (NSC-123 127) in breast cancer: an overview of studies. Cancer Chemotherap. Rep. 6/3, 319–327 (1975a)

    Google Scholar 

  • Tormey, D.C.: Combined chemotherapy and surgery in breast cancer: a review. Cancer 36, 881–892 (1975b)

    Article  CAS  Google Scholar 

  • Tormey, D.C., Simon, R.M., Lippman, M.E., Bull, J.M., Myers, C.E.: Evaluation of tamoxifen dose in advanced breast cancer. Cancer Treat. Rep. 60, 1451–1459 (1976)

    PubMed  CAS  Google Scholar 

  • Tormey, D., Carbone, P., Band, P.: Breast cancer survival in single and combination chemotherapy trials since 1968. Proc. Am. Assoc. Cancer Res. 18, 64 (1977)

    Google Scholar 

  • Welbourn, M.A., Burn, I.J.: Current concepts — treatment of advanced mammary cancer. N. Engl. J. Med. 287, 398–400 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Whitney, D.J., Smith, D.G., Szilagyi, D.E.: Meaning of five-year cure in cancer of the breast. Arch. Surg. 88, 637–644 (1964)

    Article  PubMed  CAS  Google Scholar 

  • Young, R.C., Lippman, M.E., DeVita, T.V., Bull, J., Tormey, D.C.: Perspectives in the treatment of breast cancer: 1976. Ann. Intern. Med. 86, 784–798 (1976)

    Google Scholar 

Download references

Authors
  1. Kurt W. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Alpenstraße 17, CH-3006, Bern, Schweiz

    Adolf Zuppinger

  2. Einsteinstraße 66, D-7250, Leonberg, Deutschland

    Werner Hellriegel

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Brunner, K.W. (1982). Hormon- und Chemotherapie. In: Zuppinger, A., Hellriegel, W. (eds) Mammatumoren / Tumours of the Mammary. Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology, vol 19 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95377-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-95377-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-95378-1

  • Online ISBN: 978-3-642-95377-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation